Market by Technology, Diagnostic Method, Product, Pathogen, Testing Type, and Geography | Forecast 2021-2028
As per the detailed analysis of the global sepsis diagnostics market by Triton Market Research, the market, in terms of revenue, is estimated to grow at a CAGR of 8.18% during the forecasting years 2021-2028. The market gained $605.0 million in 2020, and is expected to acquire revenue worth $900.7 million by 2028.
Report scope can be customized per your requirements. Request For Customization
Sepsis is a condition that arises due to the body’s
response to pathogenic microorganisms in the blood. Sepsis cognizance has
considerably increased over the past five years. However, the management of sepsis
still faces numerous unmet medical needs. Therefore, several multinational
companies like Roche and Siemens Healthineers undertake initiatives to raise
awareness and develop novel technologies to address these issues.
According to the World Health Organization (WHO), sepsis’s
global epidemiological burden is difficult to ascertain. It is expected to
affect more than 30 million people worldwide, possibly leading to 6 million
deaths each year. Besides, one in ten deaths associated with pregnancy and
childbirth is due to maternal sepsis. In the people affected with COVID-19
sepsis, the virus is the infection. The life-threatening organ dysfunction
includes the lungs, brain, kidneys, heart, and liver. All these factors are
contributing to the growth of the Sepsis Diagnostics market.
Triton’s report aims to get an overview of the sepsis
diagnostics market in terms of various factors. Within this report, the key
insight and the market summary regarding the market have been discussed. Also, the
Impact of COVID-19 on the market, Porter’s five forces model, market
attractiveness matrix, vendor scorecard, and key market strategies have been
studied in detail.
Market drivers such as the rise in hospital-acquired
infections among patients and increased sepsis prevalence are driving the studied
market’s growth. Additionally, the growth opportunities in the emerging
economies and rising government initiatives for research activities related to
sepsis can be leveraged by the market to reach its projected growth.
However, major restraints like the high cost associated with the instrument and reimbursement issues are obstructing the global market’s future growth.
Key geographies
covered in the sepsis diagnostics market are:
• North America: Canada and United States
• Europe:
Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe
• Asia-Pacific:
Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China,
and Rest of Asia-Pacific
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and
Rest of Middle East & Africa
The
segmentation analysis of the sepsis diagnostics market includes:
• Market by
Technology:
o Microbiology
o Immunoassay
o Molecular Diagnostics
o Other Technologies
• Market by
Diagnostic Method:
o Conventional Diagnostics
o Automated Diagnostics
• Market by
Product:
o Blood Culture Media
o Assay Kits & Reagents
o Instruments
• Market by
Pathogen:
o Gram-Positive and Gram-Negative
Bacterial Sepsis
o Fungal Sepsis
o Other
Pathogens
• Market by
Testing Type:
o Laboratory Testing
o Point-of-Care Testing
The distinguished players engaged in the sepsis diagnostics market are EKF Diagnostics, Biomerieux SA, Response Biomedical Corporation, Abbott Laboratories, Luminex Corporation, Thermo Fisher Scientific Inc, Cytosorbents, Becton Dickinson and Company (CR Bard), F Hoffmann-La Roche, T2 Biosystems Inc, Bruker Corporation, Immunexpress Inc, and Danaher Corporation.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
SEPSIS DIAGNOSTICS MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON SEPSIS DIAGNOSTICS MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. CONTRACTS
AND PARTNERSHIP
2.6.2. BUSINESS
EXPANSION AND DIVESTITURES
2.6.3. ACQUISITIONS
& MERGERS
2.6.4. NEW
PRODUCT LAUNCHES
2.7. MARKET
DRIVERS
2.7.1. RISE
IN HOSPITAL-ACQUIRED INFECTIONS AMONG PATIENTS
2.7.2. INCREASED
PREVALENCE OF SEPSIS
2.8. MARKET
RESTRAINTS
2.8.1. HIGH
COST ASSOCIATED WITH THE INSTRUMENT
2.8.2. REIMBURSEMENT
ISSUES
2.9. MARKET
OPPORTUNITIES
2.9.1. GROWTH
OPPORTUNITIES IN THE EMERGING ECONOMIES
2.9.2. RISING
GOVERNMENT INITIATIVES FOR RESEARCH ACTIVITIES RELATED TO SEPSIS
3. GLOBAL
SEPSIS DIAGNOSTICS MARKET - BY TECHNOLOGY
3.1. MICROBIOLOGY
3.2. IMMUNOASSAY
3.3. MOLECULAR
DIAGNOSTICS
3.4. OTHER
TECHNOLOGIES
4. GLOBAL
SEPSIS DIAGNOSTICS MARKET - BY DIAGNOSTIC METHOD
4.1. CONVENTIONAL
DIAGNOSTICS
4.2. AUTOMATED
DIAGNOSTICS
5. GLOBAL
SEPSIS DIAGNOSTICS MARKET - BY PRODUCT
5.1. BLOOD
CULTURE MEDIA
5.2. ASSAY
KITS & REAGENTS
5.3. INSTRUMENTS
6. GLOBAL
SEPSIS DIAGNOSTICS MARKET - BY PATHOGEN
6.1. GRAM
- POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS
6.2. FUNGAL
SEPSIS
6.3. OTHER
PATHOGENS
7. GLOBAL
SEPSIS DIAGNOSTICS MARKET - BY TESTING TYPE
7.1. LABORATORY
TESTING
7.2. POINT-OF-CARE
TESTING
8. GLOBAL
SEPSIS DIAGNOSTICS MARKET – REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY TECHNOLOGY
8.1.2. MARKET
BY DIAGNOSTIC METHOD
8.1.3. MARKET
BY PRODUCT
8.1.4. MARKET
BY PATHOGEN
8.1.5. MARKET
BY TESTING TYPE
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.2. CANADA
8.2. EUROPE
8.2.1. MARKET
BY TECHNOLOGY
8.2.2. MARKET
BY DIAGNOSTIC METHOD
8.2.3. MARKET
BY PRODUCT
8.2.4. MARKET
BY PATHOGEN
8.2.5. MARKET
BY TESTING TYPE
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. GERMANY
8.2.6.2. FRANCE
8.2.6.3. UNITED
KINGDOM
8.2.6.4. ITALY
8.2.6.5. RUSSIA
8.2.6.6. SPAIN
8.2.6.7. REST
OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY TECHNOLOGY
8.3.2. MARKET
BY DIAGNOSTIC METHOD
8.3.3. MARKET
BY PRODUCT
8.3.4. MARKET
BY PATHOGEN
8.3.5. MARKET
BY TESTING TYPE
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.2. JAPAN
8.3.6.3. INDIA
8.3.6.4. AUSTRALIA
& NEW ZEALAND
8.3.6.5. SOUTH
KOREA
8.3.6.6. ASEAN
COUNTRIES
8.3.6.7. REST
OF ASIA-PACIFIC
8.4. LATIN
AMERICA
8.4.1. MARKET
BY TECHNOLOGY
8.4.2. MARKET
BY DIAGNOSTIC METHOD
8.4.3. MARKET
BY PRODUCT
8.4.4. MARKET
BY PATHOGEN
8.4.5. MARKET
BY TESTING TYPE
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. MEXICO
8.4.6.2. BRAZIL
8.4.6.3. REST
OF LATIN AMERICA
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY TECHNOLOGY
8.5.2. MARKET
BY DIAGNOSTIC METHOD
8.5.3. MARKET
BY PRODUCT
8.5.4. MARKET
BY PATHOGEN
8.5.5. MARKET
BY TESTING TYPE
8.5.6. COUNTRY
ANALYSIS
8.5.6.1. SAUDI
ARABIA
8.5.6.2. UNITED
ARAB EMIRATES
8.5.6.3. TURKEY
8.5.6.4. SOUTH
AFRICA
8.5.6.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. ABBOTT
LABORATORIES
9.2. BECTON
DICKINSON AND COMPANY (CR BARD)
9.3. BIOMERIEUX
SA
9.4. BRUKER
CORPORATION
9.5. CYTOSORBENTS
9.6. DANAHER
CORPORATION
9.7. EKF
DIAGNOSTICS
9.8. F
HOFFMANN-LA ROCHE
9.9. IMMUNEXPRESS
INC
9.10. LUMINEX
CORPORATION
9.11. RESPONSE
BIOMEDICAL CORPORATION
9.12. T2
BIOSYSTEMS INC
9.13. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL SEPSIS DIAGNOSTICS MARKET,
REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: MARKET ATTRACTIVENESS INDEX
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5: LIST OF BUSINESS EXPANSIONS &
DIVESTITURES
TABLE 6: LIST OF ACQUISITIONS & MERGERS
TABLE 7: LIST OF NEW PRODUCT LAUNCHES
TABLE 8: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 12: GRAM-NEGATIVE BACTERIA CAUSING SEPSIS
TABLE 13: GRAM-POSITIVE BACTERIA CAUSING SEPSIS
TABLE 14: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 15: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY
REGION, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 19: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 21: NORTH AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE SEPSIS DIAGNOSTICS MARKET, COUNTRY
OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 23: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 24: EUROPE SEPSIS DIAGNOSTICS MARKET, BY DIAGNOSTIC
METHOD, 2021-2028 (IN $ MILLION)
TABLE 25: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 26: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 27: EUROPE SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 31: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 32: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 33: ASIA-PACIFIC SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET,
COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 35: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 37: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 38: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 39: LATIN AMERICA SEPSIS DIAGNOSTICS MARKET, BY
TESTING TYPE, 2021-2028 (IN $ MILLION)
TABLE 40: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 41: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY DIAGNOSTIC METHOD, 2021-2028 (IN $ MILLION)
TABLE 43: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 44: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY PATHOGEN, 2021-2028 (IN $ MILLION)
TABLE 45: MIDDLE EAST AND AFRICA SEPSIS DIAGNOSTICS
MARKET, BY TESTING TYPE, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 3: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY MICROBIOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY IMMUNOASSAY, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 7: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY DIAGNOSTIC METHOD, 2020 & 2028 (IN %)
FIGURE 8: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY CONVENTIONAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY AUTOMATED DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 11: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY BLOOD CULTURE MEDIA, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY ASSAY KITS & REAGENTS, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY PATHOGEN, 2020 & 2028 (IN %)
FIGURE 15: GLOBAL SEPSIS DIAGNOSTICS MARKET, BY GRAM -
POSITIVE AND GRAM - NEGATIVE BACTERIAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY FUNGAL SEPSIS, 2021-2028 (IN $ MILLION)
FIGURE 17: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY OTHER PATHOGENS, 2021-2028 (IN $ MILLION)
FIGURE 18: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY TESTING TYPE, 2020 & 2028 (IN %)
FIGURE 19: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY LABORATORY TESTING, 2021-2028 (IN $ MILLION)
FIGURE 20: GLOBAL SEPSIS
DIAGNOSTICS MARKET, BY POINT-OF-CARE TESTING, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL SEPSIS DIAGNOSTICS
MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 22: UNITED STATES SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: GERMANY SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 25: FRANCE SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 26: UNITED KINGDOM SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: ITALY SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: RUSSIA SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: SPAIN SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: REST OF EUROPE SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: CHINA SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: JAPAN SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 33: INDIA SEPSIS DIAGNOSTICS
MARKET 2021-2028 (IN $ MILLION)
FIGURE 34: AUSTRALIA & NEW
ZEALAND SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 35: SOUTH KOREA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 36: ASEAN COUNTRIES SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: REST OF ASIA-PACIFIC
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 38: MEXICO SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 39: BRAZIL SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 40: REST OF LATIN AMERICA
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 41: SAUDI ARABIA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 42: UNITED ARAB EMIRATES
SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 43: TURKEY SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 44: SOUTH AFRICA SEPSIS
DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)
FIGURE 45: REST OF MIDDLE EAST &
AFRICA SEPSIS DIAGNOSTICS MARKET 2021-2028 (IN $ MILLION)